Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
University of Illinois at Chicago
With
OBJECTIVES: * Determine the toxicity and safety of lycopene supplementation as chemoprevention for prostate cancer in healthy participants. * Determine the pharmacokinetics of this agent in these participants. * Determine the dose range of this agent in these participants. OUTLINE: This is a dose-escalation study. Participants ingest a single-dose of oral lycopene over a maximum of 15 minutes on day 1. Cohorts of 5 participants receive escalating doses of lycopene until the maximum tolerated dose (MTD) is determined. The MTD is defined as the dose preceding that at which 2 of 5 participants experience dose-limiting toxicity. Participants are evaluated periodically for 28 days. PROJECTED ACCRUAL: A total of 25 participants will be accrued for this study.
Age
18–45
Sex
MALE
Healthy volunteers
Accepted
